Cargando…

Predicting Phospholipidosis Using Machine Learning

[Image: see text] Phospholipidosis is an adverse effect caused by numerous cationic amphiphilic drugs and can affect many cell types. It is characterized by the excess accumulation of phospholipids and is most reliably identified by electron microscopy of cells revealing the presence of lamellar inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowe, Robert, Glen, Robert C., Mitchell, John B. O.
Formato: Texto
Lenguaje:English
Publicado: American Chemical Society 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949053/
https://www.ncbi.nlm.nih.gov/pubmed/20799726
http://dx.doi.org/10.1021/mp100103e
_version_ 1782187514957660160
author Lowe, Robert
Glen, Robert C.
Mitchell, John B. O.
author_facet Lowe, Robert
Glen, Robert C.
Mitchell, John B. O.
author_sort Lowe, Robert
collection PubMed
description [Image: see text] Phospholipidosis is an adverse effect caused by numerous cationic amphiphilic drugs and can affect many cell types. It is characterized by the excess accumulation of phospholipids and is most reliably identified by electron microscopy of cells revealing the presence of lamellar inclusion bodies. The development of phospholipidosis can cause a delay in the drug development process, and the importance of computational approaches to the problem has been well documented. Previous work on predictive methods for phospholipidosis showed that state of the art machine learning methods produced the best results. Here we extend this work by looking at a larger data set mined from the literature. We find that circular fingerprints lead to better models than either E-Dragon descriptors or a combination of the two. We also observe very similar performance in general between Random Forest and Support Vector Machine models.
format Text
id pubmed-2949053
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-29490532010-10-04 Predicting Phospholipidosis Using Machine Learning Lowe, Robert Glen, Robert C. Mitchell, John B. O. Mol Pharm [Image: see text] Phospholipidosis is an adverse effect caused by numerous cationic amphiphilic drugs and can affect many cell types. It is characterized by the excess accumulation of phospholipids and is most reliably identified by electron microscopy of cells revealing the presence of lamellar inclusion bodies. The development of phospholipidosis can cause a delay in the drug development process, and the importance of computational approaches to the problem has been well documented. Previous work on predictive methods for phospholipidosis showed that state of the art machine learning methods produced the best results. Here we extend this work by looking at a larger data set mined from the literature. We find that circular fingerprints lead to better models than either E-Dragon descriptors or a combination of the two. We also observe very similar performance in general between Random Forest and Support Vector Machine models. American Chemical Society 2010-08-27 2010-10-04 /pmc/articles/PMC2949053/ /pubmed/20799726 http://dx.doi.org/10.1021/mp100103e Text en Copyright © 2010 American Chemical Society http://pubs.acs.org This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org.
spellingShingle Lowe, Robert
Glen, Robert C.
Mitchell, John B. O.
Predicting Phospholipidosis Using Machine Learning
title Predicting Phospholipidosis Using Machine Learning
title_full Predicting Phospholipidosis Using Machine Learning
title_fullStr Predicting Phospholipidosis Using Machine Learning
title_full_unstemmed Predicting Phospholipidosis Using Machine Learning
title_short Predicting Phospholipidosis Using Machine Learning
title_sort predicting phospholipidosis using machine learning
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949053/
https://www.ncbi.nlm.nih.gov/pubmed/20799726
http://dx.doi.org/10.1021/mp100103e
work_keys_str_mv AT lowerobert predictingphospholipidosisusingmachinelearning
AT glenrobertc predictingphospholipidosisusingmachinelearning
AT mitchelljohnbo predictingphospholipidosisusingmachinelearning